A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1 - Concepedia

Concepedia

Publication | Closed Access

A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1

37

Citations

11

References

2009

Year

Priya S. Kishnani, M. DiRocco, Paige Kaplan, Atul Mehta, Gregory M. Pastores, Samantha Smith, Ana Cristina Puga, Roberta Lemay, Neal J. Weinreb

Molecular Genetics and Metabolism

Adult PatientsMaintenance TherapySubstrate Reduction TherapyRandomized TrialMedicine

References

	Year	Citations

Page 1